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Colonort obesity to be an important risk factor inﬂuencing colon pathologies, yet
mechanism(s) are unknown. Recent studies have shown signiﬁcant elevation of insulin, leptin and
triglycerides associated with increased adipose tissue. In situ hybridisation studies have located insulin,
leptin and adiponectin receptor expression in the colon epithelia. The inﬂuence of increased adiposity and
associated deregulation of insulin and adipokines on regulation of the colon epithelium is unknown. Altered
adipokine and insulin signalling associated with obesity has an impact on mitochondrial function and
mitochondrial dysfunction is increasingly recognised as a contributing factor in many diseases. Proteomics
and transcriptomics are potentially powerful methods useful in elucidating the mechanisms whereby obesity
increases risk of colon diseases as observed epidemiologically. This study investigated colon mitochondrial-
associated protein proﬁles and corresponding gene expression in colon in response to increased adiposity in
a rat model of diet induced obesity. Increased adiposity in diet-induced obese sensitive rats was found to be
associated with altered protein expression of 69 mitochondrial-associated proteins involved in processes
associated with calcium binding, protein folding, energy metabolism, electron transport chain, structural
proteins, protein synthesis and degradation, redox regulation, and transport. The changes in these
mitochondrial protein proﬁles were not correlated with changes at the gene expression level assessed
using real-time PCR arrays.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
Epidemiological studies report obesity to be an important risk
factor inﬂuencing gastrointestinal and colon pathologies [1–3] but the
mechanism(s) are unknown. A recent report by the World Cancer
Research Fund and the American Institute for Cancer Research has
identiﬁed obesity as a primary risk factor in large bowel cancer [4].
Recent studies have found obesity to be associated with colon
pathologies, alterations in metabolism, insulin signalling and in
adipokines levels [5–7] promoting speculation on the role of insulin
and adipokine signalling in colon pathology. Recent studies in our lab
have shown signiﬁcant elevation of insulin, leptin and triglycerideside gel electrophoresis; DIOS,
esity Resistant; ETC, Electron
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ll rights reserved.associated with increased adipose tissue in a rat model of diet induced
obesity [8]. Furthermore, in situ hybridisation studies have located
insulin, leptin and adiponectin receptor expression in the colon
epithelia [8]. The inﬂuence of increased adiposity and associated
deregulation of insulin and adipokines on regulation of the colon
epithelium is unknown. Obesity is also associated with a low level of
chronic oxidative stress. Previously, proteomic analysis revealed
altered regulation of redox signalling and mitochondrial functions in
the colon in response to oxidative stress [9]. Altered adipokine and
insulin signalling associated with obesity has an impact on mitochon-
drial function [10] and mitochondrial dysfunction is increasingly
recognised as a contributing factor in many human diseases including
diabetes, metabolic disease and cancer [11].
Mitochondria are intracellular double membrane-bound struc-
tures that regulate energy metabolism, cell division and cell death
[12]. Consequently mitochondrial dysfunction and damage of mito-
chondrial proteins give rise to a range of ill understood patterns of
disease [11]. Recently published proteins associated with the rat colon
mitochondria highlight the diverse functions of mitochondria in the
colon [13]. Studies investigating colon pathologies using proteomics
approaches have revealed changes to mitochondrial proteins in
response to oxidative stress [9], inﬂammation [14] and colon disease
[15,16] but none have investigated the effect of obesity. The diet
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obesity in a polygenic environment [17,18]. These rats have a
propensity to increased obesity at a range of body weights much
like humans. Increased energy intake by the diet induced obese
sensitive (DIOS) rats leads to weight gain, and consequent alterations
in biochemistry, metabolism, insulin and adipokine levels [8].
The application of organelle proteomics and parallel gene
expression analysis is a potentially powerful method to elucidate
the mechanisms whereby obesity increases risk of colon pathologies
as observed epidemiologically. Previous studies reported extensive
characterisation of mitochondrial-associated proteins extracted from
rat colon [13] and a number of the identiﬁed mitochondrial proteins
are regulated at the gene transcription level [19]. This study further
investigates colon mitochondrial-associated protein proﬁles and
parallel investigation of corresponding gene expression in colon in
response to increased adiposity in a rat model of diet induced
obesity (DIO).
2. Methods
2.1. Animals and experimental protocol
All procedures were licensed according to the Animals (Scientiﬁc
Procedures) Act of 1986 and subject to approval by the Rowett
Research Institute's Ethical Review Committee. Colons and plasma
were procured from male out bred Sprague–Dawley rats (n=8) fed a
high-energy diet (Research Diet D12266B, New Brunswick, NJ) as
described in the previously reported study [8]. Brieﬂy, after twoweeks
of high-energy diet, rats were selected from the lowest (DIOR) and
highest (DIOS) quartile of body weight for levels of obesity. All
selected rats weremaintained on the high-energy diet. After 10 weeks
of feeding the high-energy diet and prior to sacriﬁce, fat mass was
measured by Nuclear Magnetic Resonance using the EchoMRI 2004
Whole Body Composition Analyzer System (Echo Medical Systems,
Houston, USA). After 23–24 weeks of feeding the high-energy diet,
rats were euthanased with isoﬂuorane to provide colons for mito-
chondrial proteomic analysis and RNA extraction for semi-quantita-
tive real-time PCR. Colons were excised from the caecum at the ileo-
caecal valve and rinsed with sucrose tris buffer to remove contents.
Colon length measurements were recorded and a 2 cm segment was
dissected from the mid-point of the distal two thirds of the colon for
mitochondrial extraction [13].
2.2. Circulating hormones and metabolites
Plasma leptin (Linco RL-83K), insulin (Linco RL-13K) and adipo-
nectin (Linco MADP-60HK) were measured using commercially avail-
able rat/mouse-speciﬁc radioimmunoassay kits (Linco BioGenesis,
Poole, UK) as described previously [8]. Plasma glucose, triglycerides
and non-esteriﬁed fatty acids were determined as previous [18] using
the fully automated KONE analyser [20,21]. Lipid peroxidation prod-
ucts were estimated in plasma as thiobarbituric acid reactive sub-
stances (TBARS) using HPLC and ﬂuorimetric detection as previously
described [22].
2.3. Proteomics of mitochondrial enriched fractions
Mitochondria-enriched extracts were prepared using a mitochon-
drial isolation kit (MITO-ISO1, Sigma, UK) according to the manufac-
turer's instructions as previously described and optimized for
Sprague–Dawley rats for proteomic analysis [13]. Tissues wereminced
immediately prior to homogenization then centrifuged twice for
5 min at 600 ×g at 4 °C to remove debris and at 10,000 ×g to pellet
mitochondria. Mitochondrial extracts were previously assessed for
membrane integrity using transmission electron microscopy and JC-1
stain with ﬂow cytometry [13].150 μg of mitochondrial-enriched protein extracts (as estimated
by γ-globulin standard and a BioRad Bradford assay) were loaded
onto BioRad IPG strips (17 cm, pH 3–10) in 340 μl of 7 M urea, 2 M
thiourea, 4% Chaps, 2% biolyte (BioRad) and 3% DTT buffer to separate
the proteins in the ﬁrst dimension. A second dimension SDS-PAGE
step was run on an 18×18 cm linear SDS polyacrylamide gradient as
described previously [9]. The gels were then stained with colloidal
Coomassie Blue staining as described by Anderson [23]. Gels (n=16)
were imaged on a BioRad GS710 ﬂat bed imager followed by image
analysis using BioRad PD Quest Version 7.1.1. The gel with highest
spot number and quality was selected as the match set standard.
Statistically signiﬁcant altered spots were trypsin digested and
identiﬁed by Nano LC/MS/MS as previously described [13]. The
presence of multiple protein expression forms (MPEFs) associated
with the identiﬁed proteins was assessed by reference to a previously
published proﬁle of rat colon mitochondrial-associated proteins [13].
2.4. RNA extraction
RNA was extracted from 0.5 cm distal colon segments adjacent to
that used for proteomic analysis using an RNeasy Midi Kit (Qiagen,
Crawley, UK), incorporating DNase digestion. All RNA samples were
subjected to analysis using a NanoDrop Spectrophotometer (Nano-
Drop Technologies, LabTech International, UK) for quantiﬁcation and
the Agilent Bioanalyser (Agilent Technologies, Bracknell, UK) to ensure
quality was sufﬁcient for semi-quantitative gene expression analysis.
2.5. Real-time PCR arrays
Total RNA (1 μg) was reverse transcribed using an RT PCR Array
First Strand kit (Tebu-Bio, UK) according to the manufacturer's
instructions. A custom designed RT Proﬁler PCR Array (SuperArray
Bioscience Corporation) was used to assess comparative gene
expression of 44 target genes (Table 1) encoding the mitochondrial
proteins showing altered expression patterns in response to increased
adiposity. Three targets were excluded because primers were
unavailable from SuperArray. Due to plate layout constraints, it was
necessary to omit one further target hence calmodulin was also not
analysed by PCR array. Two reference genes commonly used in real-
time PCR studies were selected, glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) and hypoxanthine guanine phosphoribosyl
transferase (HPRT). GAPDH was selected since evidence from pre-
vious studies indicates absence of signiﬁcant differences in GAPDH
gene expression in rat colon tissue in response to disease [24].
HPRT was also selected since this provides normalised expression
data for cross-referencing results normalised to an alternative
transcript, as advised by Ropenga et al. [25]. The design incorporated
each target and reference genes in technical duplicates on each 96-
well PCR array plate. Controls consisted of template RNA processed
for PCR without the addition of reverse transcriptase to assess non-
speciﬁc ampliﬁcation and ensure that subsequent threshold cycles
were assessed from speciﬁc ampliﬁcation of gene targets and a
synthetic RNA control to ensure efﬁcient levels of reverse transcrip-
tion are achieved. A melt curve programme was run immediately
following the cycling programme to establish the absence of non-
speciﬁc ampliﬁcation products. Amplicons generated on the PCR
array plates were also size checked by electrophoresis using 1%
NuSieve GTG agarose (Cambrex, UK) gel and tri-acetate buffer with a
Hyperladder V DNA ladder (Bioline, UK). A two-step thermocycling
programme was performed using the ABI 7500Fast (Applied
Biosystems, UK) using SuperArray SYBR green master mix (Tebu-
Bio, UK) formulated for use with the ABI platform. Cycling consisted
of an initial step of 10 min at 95 °C to activate the HotStart DNA
polymerase, followed by 40 cycles of 15 s at 95 °C and 1 min at 60 °C.
The threshold cycle number (Ct) was measured using the ABI7500Fast
and its associated software (Applied Biosystems, UK). The PCR
Table 1
Mitochondrial-associated proteins signiﬁcantly altered with increased adiposity
Spot No Protein ID Accession no Gene Mr/pI of spot MPEF Functional group
10 Calmodulin 3CLN 15.64/4.1 2 CB
107 Calmodulin 3CLN 16.04/4.1 2 CB
802 Similar to protein kinase C substrate 80 K-H Q921X2 Prkcsh_predicted 80.31/4.8 0 CB
604 Calreticulin precursor JH0819 Calr 51.11/4.88 3 CB & PF
2808 NADH-ubiquinone oxidoreductase 75 kDa subunit Q8BM16 Ndufs1 77.89/6.00 2 EM
3404 NAD+-speciﬁc isocitrate dehydrogenase a-subunit Q99NA5 Idh3a 39.03/6.32 4 EM
3405 NAD+-speciﬁc isocitrate dehydrogenase a-subunit Q99NA5 Idh3a 38.69/6.48 4 EM
3611 Mitochondrial aldehyde dehydrogenase Q8 K3 V8 Aldh2 51.26/6.44 2 EM
3617 Mitochondrial aldehyde dehydrogenase Q8K3V8 Aldh2 52.46/6.59 2 EM
4702 Glycerol-3-phosphate dehydrogenase (EC 1.1.99.5), mitochondrial precursor A54051 Gpd2 67.44/6.73 1 EM
4721 Similar to methylmalonyl-coenzyme A mutase Q8VED0 Mut 72.83/6.78 0 EM
5409 Isovaleryl-CoA dehydrogenase (EC 1.3.99.10) precursor C34252 Ivd 40.48/6.9 2 EM
6111 Electron transfer ﬂavoprotein alpha chain precursor A31568 Etfa 23.69/7.98 1 EM
6414 Creatine kinase (EC 2.7.3.2) precursor, mitochondrial S17189 Ckmt1 41.6/7.87 5 EM
6501 Glutamate dehydrogenase [NAD(P)] (EC 1.4.1.3) precursor S03707 Glud1 49.52/7.44 4
6504 Glutamate dehydrogenase [NAD(P)] (EC 1.4.1.3) precursor S03707 Glud1 49.25/7.63 4 EM
1505 ATP synthase beta chain, mitochondrial precursor (EC 3.6.3.14) ATPB_RAT Atp5b 48.4/5.47 13 ETC
1510 ATP synthase beta chain, mitochondrial precursor (EC 3.6.3.14) ATPB_RAT Atp5b 48.98/5.7 13 ETC
1607 ATP synthase beta chain, mitochondrial precursor (EC 3.6.3.14) ATPB_RAT Atp5b 55.29/5.51 13 ETC
2003 Cytochrome c oxidase subunit vb BAA01743 Cox5b 15.2/6.04 1 ETC
2108 ATP synthase D chain, mitochondrial⁎ (EC 3.6.3.14) ATPQ_RAT Atp5h 21.67/6.13 2 ETC
2213 F1-atpase beta chain 1MABB Atp5b 27.71/5.81 13 ETC
2508 Ubiquinol cytochrome c reductase BAB27022 Uqcrc1 46.93/5.94 1 ETC
3108 ATP synthase D chain, mitochondrial⁎ (EC 3.6.3.14) ATPQ_RAT Atp5h 22.72/6.16 2 ETC
3618 DLST dihydrolipoamide succinyltransferase Q8CJG5 Dlst 53.13/6.6 4 ETC
3619 DLST dihydrolipoamide succinyltransferase Q8CJG5 Dlst 52.89/6.45 4 ETC
3710 Dihydrolipoamide S-acetyltransferase⁎ (EC 2.3.1.12) S21766 Dlat 63.97/6.36 4 ETC
4402 NADH dehydrogenase 1 alpha subcomplex 10-like protein Q80WE0 Ndufa10 40.39/6.74 3 ETC
4406 NADH dehydrogenase 1 alpha subcomplex 10-like protein⁎ Q80WE0 Ndufa10 39.44/6.91 3 ETC
6108 Ubiquinol-cytochrome-c reductase (EC 1.10.2.2) Rieske iron–sulfur protein precursor A32296 Uqcrfs1 24.79/7.88 1 ETC
6202 Cytochrome c1 BAB22380 Cyc1_predicted 29.43/7.44 1 ETC
6623 Dihydrolipoamide dehydrogenase (e3 component) AAH62069 Dld 52.57/7.44 4 ETC
8215 DLST dihydrolipoamide succinyltransferase Q8CJG5 Dlst 27.76/9.56 4 ETC
319 Class II histocompatibility antigen RT1-D alpha(u) chain precursor S06316 RT1-Da 30.16/4.93 0 Other
1320 SWIPROSIN 1 Q8C845 Efhd2 31.07/5.52 0 Other
4304 Aﬂatoxin B1 aldehyde reductase member 2 AR72_RAT Akr7a2 35.77/6.92 0 Other
4605 Hypothetical protein Q8BH86 61.7/6.83 0 Other
1508 chaperonin groEL precursor HHRT60 Hspd1 49.9/5.69 4 PF
1707 dnaK-type molecular chaperone precursor HHRTGB Hspa5 72.57/5.53 5 PF
1709 dnaK-type molecular chaperone precursor HHRTGB Hspa5 71.92/5.58 5 PF
3706 dnaK-type molecular chaperone hsc73 S07197 Hspa8 65.81/6.25 3 PF
3709 dnaK-type molecular chaperone grp75 precursor I56581 Hspa9a_predicted 67.45/6.32 5 PF
3721 dnaK-type molecular chaperone hsc73 S07197 Hspa8 66.73/6.26 3 PF
2112 Phosphatidylethanolamine-binding protein PEBP_RAT 22.55/5.99 0 PSD
3103 Mitochondrial Lon protease Q924S5 Prss15 25.82/6.35 1 PSD
3109 Serine carboxypeptidase 1 AAK84661 Scpep1 18.07/6.22 0 PSD
3720 Neurolysin (metallopeptidase m3 family) CAA60630 Nln 72.79/6.61 1 PSD
5705 Methylcrotonoyl-coenzyme a carboxylase 1 alpha AAH21382 Mccc1 74.69/7.15 1 PSD
7417 Branched chain aminotransferase 2 AAH61790 Bcat2 39.37/8.12 2 PSD
2110 Thiol-speciﬁc antioxidant peroxiredoxin 2 A57716 Prdx2 21.43/5.84 1 Redox
7112 Superoxide dismutase (EC 1.15.1.1) (Mn) precurso DSRTN Sod2 23.16/8.79 3 Redox
3104 RhoA precursor BAC36896 Rhoa 25.32/6.53 0 Structural
5702 WD repeat domain 1 Q9DBM8 63.74/7.09 0 Structural
1304 Desmin DESM_RAT Des 34.81/5.28 6 Structural
1311 Keratin, type II cytoskeletal 8 K2C8_RAT Krt2-8 36.29/5.58 12 Structural
1318 Desmin DESM_RAT Des 35.66/5.3 6 Structural
1419 Keratin 21, type I, cytoskeletal A40452 Krt20 39.55/5.38 2 Structural
1421 Keratin 21, type I, cytoskeletal A40452 Krt20 39.56/5.26 2 Stuctural
1507 Keratin, type II cytoskeletal 8 K2C8_RAT Krt2-8 43.28/5.58 12 Structural
1803 Actin beta ATRTC Actb 78.86/5.44 9 Structural
1813 Filamin A FLNA_MOUSE 78.7/5.52 0 Structural
2211 Actin beta ATRTC Actb 27.5/5.95 9 Structural
2212 Actin beta ATRTC Actb 25.72/5.69 9 Structural
2511 Actin gamma 1 ATHUG 43.46/5.94 0 Structural
2814 Spectrin alpha AAC33127 Spna2 116.5/5.81 1 Structural
3411 Lamin A LAMA_RAT Lmna 39.88/6.37 0 Structural
5605 Ezrin Q8VHK3 Vil2 57.78/7.18 3 Structural
2116 GTP-binding protein Rab1 TVRTYP Rab1 21.31/5.99 0 Transport
8211 Voltage-dependent anion-selective channel protein 1 POR1_RAT Vdac1 30.05/9.68 3 Transport
CB=Calcium binding, EM=energy metabolism, ETC=electron transport chain, PF=protein folding, PSD=protein synthesis and degradation. Proteins in bold represent those signiﬁ-
cantly down regulated in DIOS rats (pb0.05). Genes for the 44 targets investigated using real-time PCR array are indicated. Known MPEFs identiﬁed previously by Padidar et al. [13].
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manufacturer (SuperArray, USA). The Ct values were obtained from
linear ampliﬁed regions of the PCR proﬁles and exported to an Excelspreadsheet. Relative transcript levels were calculated for each
reaction using the ΔΔCt method with GAPDH and HPRT as the
reference genes. Subsequent fold expression changes between the
Table 2
Signiﬁcantly altered fat mass and plasma leptin, insulin and triglyceride levels in DIOR
and DIOS rats
DIOR DIOS
Fat mass (g) 61.2 (95% CI: 48.9–73.6) 121.2 (95% CI: 105.4–136.9)
Plasma leptin (ng/ml) 14.5 (95% CI: 11.2–17.8) 20.2 (95% CI: 17.1–23.4)
Plasma insulin (ng/ml) 1.45 (95% CI: 0.82–2.08) 1.96 (95% CI: 1.25–2.66)
Plasma trigylcerides (mmol/l) 2.001 (95% CI: 1.08–2.80) 2.69 (95% CI: 1.88–3.79)
Body fat mass was signiﬁcantly elevated (pb0.01) in DIOS rats (n=8) Data for body fat
mass prior to sacriﬁce is shown. Plasma leptin, insulin and triglycerides were
signiﬁcantly (pb0.05) elevated in DIOS rats (n=8).
535S. Padidar et al. / Biochimica et Biophysica Acta 1782 (2008) 532–541DIOR and DIOS groups relative to GAPDH and HPRT were calculated
from the ΔΔCt values.
2.6. Statistical analysis
Student's t-test (pb0.05) was carried out on all measured indices
of obesity, logged proteomic data and ΔCt real time PCR data. Principal
component analysis was carried out on all resolved proteins; whilst
partial least squares analysis was carried out on 69 signiﬁcantly
altered proteins together with the measured indices of obesity. A
randomisation test on PLS analysis data revealed PLS plot was not a
random result.
3. Results
3.1. Body weight and fat mass analysis
Body weights of the DIOR and DIOS rats (n=8) were signiﬁcantly
(pb0.05) different between the groups throughout the experiment
(Fig. 1). Fat masses were also signiﬁcantly different between the DIOR
and DIOS groups (Table 2) and were signiﬁcantly correlated with body
weights r2=0.6534, pb0.01 level (2 tail test).
3.2. Circulating hormones and metabolites
Signiﬁcant (pb0.05) increases in circulating hormones (Table 2),
leptin and insulin and triglycerides were measured in DIOS rats (n=8).
There was no signiﬁcant difference in adiponectin, glucose, NEFA or
TBARS between DIOR and DIOS groups (data not shown).
3.3. Proteomics of colon mitochondrial enriched fraction
Seven hundred and ﬁfty mitochondrial-associated proteins were
resolved on 2D gels (n=8). Principal Component Analysis (PCA) is
often used to reduce multidimensional data sets, such as those from
proteomics and transcriptomics, to a simpliﬁed graph revealing the
sometimes hidden simpliﬁed structure that underlie the data.
Principal component analysis (Fig. 2A) applied to all 750 resolved
spots revealed increased adiposity was associated with altered
proﬁles of colon mitochondrial-associated proteins with 16% of the
variation most signiﬁcantly correlated with body weight (pb0.01).
Student t-test of logged protein intensity data revealed 174 signiﬁ-
cantly altered spots (pb0.05) that were subjected to visual inspection
to ensure the spot was present on at least 4 replicate gels and to
eliminate those of insufﬁcient quantity for downstream analysis. This
resulted in the ﬁnal selection of a subset of 69 spots ranging in pI from
4.1 to 9.68 with a size range from 15.2 to 116.5 kDa that were excised
and subject to LC/MS/MS analysis (Table 1). Partial Least Squares (PLS)
analysis speciﬁes the linear relationship between variables e.g. body
mass and a particular protein. This is a useful tool identifying proteinsFig. 1. Body mass of DIOR and DIOS rats (n=8) remained signiﬁcantly different (pb0.05)
in response to feeding high-energy diet.for further investigation. PLS analysis (Fig. 2B) of the 69 spots with the
hormone, biochemical and body composition data (see above)
identiﬁed potential relationships between the signiﬁcantly altered
mitochondrial-associated proteins and indices of obesity. Twenty-
seven proteins were positively associated with body adiposity e.g.
dnaK-type molecular chaperone hsc73 (Fig. 2B, spot 3721), whilst 42
proteins (in the shaded area of Fig. 2B) such as voltage-dependant
anion selective channel protein 1 (Fig. 2B, spot 8211) were inversely
associated. However, measured indices of obesity were not associated
with a particular functional group of modulated proteins.
LC/MS/MS of the 69 altered proteins identiﬁed proteins involved in
redox regulation, calcium binding, energy metabolism, electron trans-
port chain, protein synthesis and degradation, transport, structural
proteins and protein folding (Table 1, Figs. 3-7). Identiﬁed proteins
(Table 1) were compared against proteins identiﬁed by Padidar et al.
[13] to establish the presence ofMPEFs. This revealed that 48 out of the
69 signiﬁcantly altered proteins were associated with one or more
previously identiﬁedMPEFs in the ratmitochondrial-enriched extracts
(Table 1). There was an overall down-regulation of MPEFs of proteins
involved in energy metabolism (Fig. 4A), electron transport chain
(Fig. 4B), protein folding (Fig. 5A) and structural proteins (Fig. 6A) with
increased adiposity. The calcium binding protein calmodulin had
altered expression proﬁles with a change in proteinmass in colon from
DIOS rats (Fig. 7A–C), highlighting the importance of post-translational
modiﬁcations to proteins.
3.4. Real-time PCR array
Real-time PCR array performed on 44 of the 48 genes encoding for
the signiﬁcantly altered mitochondrial-associated proteins by proteo-
mics (listed in Table 1) were ampliﬁed successfully, yielding single
ampliﬁed products of the correct size (data not shown). Fold
expression changes of the selected nuclear-encoded mitochondrial
target genes (listed in Table 1) from total RNA extracted from colon
segments adjacent to that used for proteomic analysis of DIOR and
DIOS rats were calculated relative to the reference genes GAPDH and
HPRT. Despite alteration in the expression patterns of the proteins
encoded by these gene targets in response to increased adiposity there
was no evidence of signiﬁcant altered regulation at the gene trans-
cription level (data not shown).
4. Discussion
To our knowledge this is the ﬁrst study to investigate the impact of
increased adiposity on colon mitochondrial-associated proteins and
their corresponding encoding genes. Employing the diet induced
obesity rat model of obesity [17,18,26], the DIOR and DIOS rats fed a
high-energy diet have signiﬁcant differences in body weight (Fig. 1)
and fat mass (Table 2) [8]. This increased fat mass in DIOS rats was
associated with signiﬁcant elevation of obesity markers, leptin,
insulin, and triglycerides (Table 2) [8], all linked to an increase risk
of colon cancer [27,28]. The elevated fat mass in DIOS rats did not
result in signiﬁcantly altered plasma adiponectin levels counter to
reports of reduced plasma adiponectin with increased obesity [29].
Fig. 2. (A) Principal component analysis of 750 proteins revealed clustering of the data by body mass. (B) Partial Least Squares analysis was applied to the 69 signiﬁcantly altered
proteins to identify potential relationships between the proteins (square) and the measured indices of obesity (triangle). Spot numbers identiﬁed in Table 1. Proteins in the shaded
area are inversely associated with body weight, fat mass, leptin and insulin levels.
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Sixty-nine mitochondrial-associated protein proﬁles were signiﬁ-
cantly altered as a result of increased adiposity in DIOS rats,
compared with DIOR. Twenty-seven proteins were associated with
increased adiposity and body weight (Fig. 2B). Altered proteins were
involved in calcium binding, protein folding, energy metabolism,
electron transport chain, structural proteins, protein synthesis and
degradation, redox regulation, and transport (Table 1, Figs. 3-7),
reﬂecting the broad functional groups of proteins previously found in
colon mitochondria [13]. Sixty one percent of the colon mitochon-
drial-associated proteins were down regulated in the DIOS rats.
Principal Component Analysis (PCA) is often used to reduce multi-
dimensional data sets, such as those from proteomics and transcrip-
tomics, to a simpliﬁed graph revealing the sometimes hiddensimpliﬁed structure that underlie the data. The PCA plot (Fig. 2A)
shows graphically there is a signiﬁcant difference between the
protein proﬁles of DIOR and DIOS rats, which was found correlating
most signiﬁcantly with body weight.
4.2. Energy metabolism and electron transport chain
Forty two percent of the colon mitochondrial-associated proteins
modulated in DIOS rats were involved in the electron transport chain
(ETC) and energy metabolism (Fig. 4), indicative of a major function of
mitochondria. Over half of these were down regulated in the DIOS rat
(Fig. 4A, B) suggesting a decrease in ATP production with increased
adiposity, supporting observations of decreasedmuscle mitochondrial
ATP production in rats fed a high-energy diet independent of diet
composition [30]. A multiple protein expression form (MPEF) of ATP
Fig. 3. Percentage of the 69 mitochondrial-associated modulated proteins in DIOR and
DIOS rats (n=8) in each functional group.
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ﬂavoprotein alpha (Fig. 4A, spot 6111), down regulated in DIOS rats,
have also previously been found to be down regulated in oxidative
stress [9] and aged human colonic epithelium [31]. Down-regulation
of ATP synthase beta subunit in skeletal muscle of patientswith type-2
diabetes is thought to be due to phosphorylation of this subunit,
therefore altering the regulation of ATP synthesis and contributing to
the pathogenesis of type-2 diabetes, a disease signiﬁcantly associated
with obesity [32] and colon cancer [33]. Creatine kinase precursor was
up regulated in the DIOS group (Fig. 4A, spot 6414). Creatine kinases
are normally found in cells with a high or ﬂuctuating energy demands
by shuttling ‘high-energy’ phosphates formed in mitochondria and
transporting to the cytosol [34,35]. Mitochondrial creatine kinase (EC
2.7.3.2) is located in the intermembrane compartment [36] and uses
ATP to form phosphocreatine [37], which is transported to the cytosol
using voltage-dependent anion channel (VDAC) [38,39] for the
phosphorylation of ADP to ATP by cytosolic creatine kinase [34,35].
Up regulation of mitochondrial creatine kinase precursor in the DIOSFig. 4. Signiﬁcant changes to proteins involved in energy metabolism (A) and electron transp
Proteins 6504, 1505, 2003, 2508 and 6108 use the right hand scales.groupmay be a compensatory response to down regulation of ETC and
VDAC1 proteins thus augmenting a decrease in ATP production in the
DIOS group.
4.3. Protein folding and transport
Nine signiﬁcantly modulated proteins were involved in transport
and protein folding; seven of these proteins were down regulated in
the DIOS rats (Fig. 5). VDAC 1 (Fig. 5B, spot 8211), forms a pore on
the outer mitochondrial membrane, allowing the passage of small
ionic and hydrophilic molecules e.g. ATP, into the membrane, in a
calcium dependent manner. VDAC is a candidate component of the
permeability transition pore, thought to participate in both apoptotic
and necrotic cell deaths [40,41]. VDAC1 has been shown to co-
immunoprecipitate with the anti-apoptotic protein Bcl-2 and has
been suggested to be involved in forming the pore that releases
cytochrome c during apoptosis [42]. Previous proﬁling of the colon
mitochondrial-associated proteins of the rat colon has revealed three
MPEFs of VDAC1 [13]. This study found one of these MPEFs to be
down regulated in the DIOS group. Since apoptosis requires the
maintenance of N65% of normal ATP concentration in the cell and a
severe or prolonged decrease in ATP concentration (b20%) leads to
necrosis [43,44], it is possible that any decreased ATP level and
down regulation of VDAC1 and ETC proteins, associated with in-
creased adiposity, could lead to a delay in mitochondrial-coordinated
apoptotic processes. Apoptosis is a key event in colon epithelial reg-
ulation where stem cells originating at the base of the crypt are
thought to differentiate and migrate up the crypt length, followed
by apoptosis and sloughing off into the luminal tract (reviewed in
[45]). Changes to apoptotic events may give rise to aberrant crypt foci,
potentially an early stage marker of colon cancer histology (reviewed
in [45]).
Many proteins require an association with one or more types of
molecular chaperones, during their synthesis, transport, folding and
degradation within cells. Many expression forms of these proteins
were found down regulated in DIOS rats. The heat shock proteinsort chain (B) in DIOR and DIOS rats (n=8) (pb0.05). Spot numbers identiﬁed in Table 1.
Fig. 5. Signiﬁcant changes to proteins involved in protein folding (A) and transport (B) in DIOR and S rats (n=8) (pb0.05). Note: Log scale used for protein intensity of transport
proteins. Spot numbers identiﬁed in Table 1.
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Hsp60 (Fig. 5A, spot 1508), down regulated in the DIOS group, is an
essential mitochondrial chaperone and promotes the folding of
several proteins imported into the mitochondrial matrix [47,48]. It
may also prevent misfolding and promote the refolding and proper
assembly of unfolded polypeptides generated under stress conditions
in the mitochondrial matrix [49]. Expression forms of HSC73 (Fig. 5A,
spot 3706, 3721) were found modulated in DIOS compared with DIOR
rats, with a change in mass, similar to calmodulin (see below Calcium
binding). It is a member of the hsp70 protein family and is involved
with the uncoating of clathrin-coated vesicles [50] and transport of
cytoplasmic proteins to lysosomes for degradation [51]. Alterations inFig. 6. Signiﬁcant changes to proteins involved in structural proteins (A), protein synthesis a
numbers identiﬁed in Table 1. Proteins 1311 and 2511 use the right hand scale.these chaperone proteins may lead to misfolding and transport of
proteins with downstream consequences.
4.4. Structural proteins
Twenty three percent of the modulated colon mitochondrial-
associated proteins were structural proteins (Fig. 6A); with over half of
these down regulated in DIOS rats. A down regulation of some MPEFs
of actin beta (Fig. 6A, spots 1803, 2211 and 2212) was found in DIOS
rats, suggesting alterations in normal patterns of cell death [52].
Modulation of structural proteins such as actin beta and keratins also
highlight the close interaction of mitochondria with microtubulesnd degradation (B) and redox regulation (C) in DIOR and DIOS rats (n=8) (pb0.05). Spot
Fig. 7. Change in molecular weight of calmodulin (spot 10 and 107) with increased
adiposity. (A) Representative gel from DIOR rats, (B) representative gel from DIOS rats.
(C) Signiﬁcant changes to calmodulin DIOR and DIOS rats (n=8) (pb0.05), log scale for
protein intensity used. Spot numbers identiﬁed in Table 1. The protein intensities of
spots 10 and 107 (calmodulin) were not signiﬁcantly different from each other.
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within cells [53,54]. This implies that the proteins associated with
mitochondrial-enriched fractionsmay be linked to normal functioning
of mitochondria in the colon. For example, desmin (Fig. 6A, spots 1304
and 1318) serves an important role in the maintenance of cellular
integrity of muscle tissues [55,56]. In desmin-null mice, mitochondrial
abnormalities are the ﬁrst visible defect, including loss of shape and
positioning, proliferation, aggregation, swelling, degeneration, dimin-
ished ADP-stimulated respiratory function and loss of creatine kinase
coupling (reviewed in [54]). This study has found changes to the
desminproﬁle in the colons of DIOR andDIOS rats, thus supporting the
hypothesis that obesity inﬂuences mitochondrial function in colonic
tissue that may have implications for colon health.
4.5. Calcium binding
Proteins involved in calcium binding (Fig. 7C) such as calmodulin
and calreticulin have beenpreviously foundmodulated in colon cancer
[57,58]. The modulation of these proteins reﬂects the intimate
relationship between mitochondria and other vesicular membranes
such as the endoplasmic reticulum for calciumhomeostasis [59]. These
proteins may also work closely with the structural proteins such as
actins in exo- and endocytosis [60]. The down regulation of 3 out of 4
signiﬁcantly altered calcium binding proteins with increased adiposity
suggests effects on calcium homeostasis known to regulate a number
of cell processes including cell death. Calmodulin was found in a
different location in DIOR and DIOS gels (Fig. 7A–C, spots 10 and 107).
An increase in molecular weight by 0.4 kDa (15.64 and 16.04) and
no change in pI (4.1) in the DIOS gels (Fig. 7B), suggested a post-
translational modiﬁcation, such as phosphorylation as induced by
insulin [61].4.6. Redox regulation
Therewas a down regulation of someMPEFs of redox proteins such
as superoxide dismutase and peroxiredoxin 2 (Fig. 6C) in DIOS rats.
MPEFs of these proteins were identiﬁed from the previous study
proﬁling mitochondrial-associated proteins from rat colon [13]. In the
case of superoxide dismutase, three MPEFs were identiﬁed by Padidar
et al. [13] and one of these was signiﬁcantly down regulated in the
DIOS rats. Down regulation of redox proteins correlates with increased
oxidative stress seenwith chronic obesity [62], however, the DIOS rats
did not have signiﬁcantly increased plasma oxidative stress as
measured by TBARS (data not shown). This may reﬂect a lack of
sensitivity in the TBARS assay applied in this particular rat model as
opposed to other rodent models studies investigating oxidative stress
and application of the TBARS assay [9]. Analysis of enzyme activity of
superoxide dismutase using established assays [63] also did not reveal
signiﬁcant differences in activity associated with increased adiposity
(unpublished observation). It may be that although one particular
MPEF was down-regulated the overall level of total protein may not
have signiﬁcantly altered.
In summary, the changes to the colon mitochondrial-associated
protein proﬁles associatedwith increased adiposity suggest a decrease
in ATP production, apoptosis, protein folding and mitochondrial
positioning. Colons taken from DIOR and DIOS rats do not show gross
differences in morphology on histological analysis [8]. The altered
mitochondrial-associated protein proﬁle changes observed in this
study may provide clues to mitochondrial-regulated functions in the
colons of obese subjects preceding colon pathologies [1–3].
4.7. Gene expression of modulated proteins
The MPEFs generated by post-translational modiﬁcation, observed
frequently as a consequence of proteomic analysis, are often the
product of a single gene. A transcriptomic approach was employed
here to further investigate regulation of the colon mitochondrial-
associated proteins since it is known that many mitochondrial
proteins are also regulated at the gene transcription level (for review
see 34). Real-time PCR is costly and labour intensive and selecting
targets from the numerous proteins identiﬁed from proteomic
analysis presents a dilemma. The RT PCR array approach adopted
here presents a solution, allowing custom design and rapid screening
of numerous targets simultaneously. Forty-four target genes corre-
sponding to the majority (85%) of the identiﬁed mitochondrial
proteins showing altered expression patterns were successfully
assessed at the gene transcription level using a custom designed
PCR array approach. There are many studies in the literature that have
found a poor correlation between microarray data and proteomic data
[64] suggesting various levels of regulation during protein synthesis
e.g. translational, post-translational and post-transcriptional regula-
tion. The lack of robust changes at the gene transcription level in this
study is also perhaps indicative of the ability of the mitochondria to
regulate homeostatic functions in response to increased adiposity at
the post-transcription level. Notably, both reference genes gave
similar results and increase conﬁdence in the use of these two
transcripts for further semi-quantitative gene expression studies in
colon. Potentially the altered protein expressions observed may lead
to altered regulation of downstream gene targets not present on the
PCR array.
The mechanisms and genotype that cause the phenotypic dif-
ferences between DIOR and DIOS rats have not yet been elucidated.
Previous studies have found DIOS rats consume approximately 25%
more energy (personal communication, Zoe Archer), changes to hypo-
thalamic gene expression (reviewed in [65]) and increased hepatic
acetyl CoA carboxylase [66] This study found DIOS rats with a pro-
pensity to increased body weight to have an associated altered colon
540 S. Padidar et al. / Biochimica et Biophysica Acta 1782 (2008) 532–541mitochondrial protein proﬁle and biochemistry. Since the Sprague
Dawley strain used in this study is out bred it is considered unlikely
that the altered mitochondrial proﬁles are due to a single genetic
mutation. However, this study does not rule out the possibility that there
may be genotypic factors that contribute to the altered proﬁles observed.
5. Summary
Increased adiposity in DIOS rats was associated with altered
protein expression of 69 mitochondrial-associated proteins involved
in processes associated with calcium binding, protein folding, energy
metabolism, electron transport chain, structural proteins, protein
synthesis and degradation, redox regulation, and transport. Although
this investigation did not ﬁnd changes to mitochondrial protein
proﬁles to correlate changes to gene expression, real-time PCR arrays
were found to be a successful, high throughput and valid approach in
investigating proteomic and gene expression in parallel.
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